-
1
-
-
33744908869
-
Drug evaluation: ADI-PEG-20- A PEGylated arginine deiminase for arginine-auxotrophic cancers
-
Shen, L. J.; Shen, W. C. Drug evaluation: ADI-PEG-20- a PEGylated arginine deiminase for arginine-auxotrophic cancers Curr. Opin. Mol. Ther. 2006, 8, 240-248
-
(2006)
Curr. Opin. Mol. Ther.
, vol.8
, pp. 240-248
-
-
Shen, L.J.1
Shen, W.C.2
-
2
-
-
84879550695
-
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
-
Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E. W.; Wu, B. W.; Bomalaski, J. S.; Venhaus, R.; Pan, L.; Old, L. J.; Pavlick, A. C.; Wolchok, J. D. Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma Invest. New Drugs 2013, 31, 425-434
-
(2013)
Invest. New Drugs
, vol.31
, pp. 425-434
-
-
Ott, P.A.1
Carvajal, R.D.2
Pandit-Taskar, N.3
Jungbluth, A.A.4
Hoffman, E.W.5
Wu, B.W.6
Bomalaski, J.S.7
Venhaus, R.8
Pan, L.9
Old, L.J.10
Pavlick, A.C.11
Wolchok, J.D.12
-
3
-
-
77957245576
-
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
-
Yang, T. S.; Lu, S. N.; Chao, Y.; Sheen, I. S.; Lin, C. C.; Wang, T. E.; Chen, S. C.; Wang, J. H.; Liao, L. Y.; Thomson, J. A.; Wang-Peng, J.; Chen, P. J.; Chen, L. T. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients Br. J. Cancer. 2010, 103, 954-960
-
(2010)
Br. J. Cancer.
, vol.103
, pp. 954-960
-
-
Yang, T.S.1
Lu, S.N.2
Chao, Y.3
Sheen, I.S.4
Lin, C.C.5
Wang, T.E.6
Chen, S.C.7
Wang, J.H.8
Liao, L.Y.9
Thomson, J.A.10
Wang-Peng, J.11
Chen, P.J.12
Chen, L.T.13
-
4
-
-
77952316981
-
Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma
-
Glazer, E. S.; Piccirillo, M.; Albino, V.; Di Giacomo, R.; Palaia, R.; Mastro, A. A.; Beneduce, G.; Castello, G.; De Rosa, V.; Petrillo, A.; Ascierto, P. A.; Curley, S. A.; Izzo, F. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma J. Clin. Oncol. 2010, 28, 2220-2226
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 2220-2226
-
-
Glazer, E.S.1
Piccirillo, M.2
Albino, V.3
Di Giacomo, R.4
Palaia, R.5
Mastro, A.A.6
Beneduce, G.7
Castello, G.8
De Rosa, V.9
Petrillo, A.10
Ascierto, P.A.11
Curley, S.A.12
Izzo, F.13
-
5
-
-
77955737883
-
Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma
-
Yang, H.; Lin, M.; Xiong, F. X.; Yang, Y.; Nie, X.; Zhou, R. L. Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma Oncol. Lett. 2010, 1, 31-36
-
(2010)
Oncol. Lett.
, vol.1
, pp. 31-36
-
-
Yang, H.1
Lin, M.2
Xiong, F.X.3
Yang, Y.4
Nie, X.5
Zhou, R.L.6
-
6
-
-
0037430556
-
Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase
-
Shen, L. J.; Lin, W. C.; Beloussow, K.; Shen, W. C. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase Cancer Lett. 2003, 191, 165-170
-
(2003)
Cancer Lett.
, vol.191
, pp. 165-170
-
-
Shen, L.J.1
Lin, W.C.2
Beloussow, K.3
Shen, W.C.4
-
7
-
-
28844493579
-
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase
-
Shen, L. J.; Beloussow, K.; Shen, W. C. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase Cancer Lett. 2006, 231, 30-35
-
(2006)
Cancer Lett.
, vol.231
, pp. 30-35
-
-
Shen, L.J.1
Beloussow, K.2
Shen, W.C.3
-
8
-
-
51949087021
-
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
-
Bowles, T. L.; Kim, R.; Galante, J.; Parsons, C. M.; Virudachalam, S.; Kung, H. J.; Bold, R. J. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase Int. J. Cancer 2008, 123, 1950-1955
-
(2008)
Int. J. Cancer
, vol.123
, pp. 1950-1955
-
-
Bowles, T.L.1
Kim, R.2
Galante, J.3
Parsons, C.M.4
Virudachalam, S.5
Kung, H.J.6
Bold, R.J.7
-
9
-
-
79953246985
-
RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
-
Wu, F. L.; Liang, Y. F.; Chang, Y. C.; Yo, H. H.; Wei, M. F.; Shen, L. J. RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells J. Biomed. Sci. 2011, 18, 25
-
(2011)
J. Biomed. Sci.
, vol.18
, pp. 25
-
-
Wu, F.L.1
Liang, Y.F.2
Chang, Y.C.3
Yo, H.H.4
Wei, M.F.5
Shen, L.J.6
-
10
-
-
0035849873
-
The heparin-binding haemagglutinin of M tuberculosis is required for extrapulmonary dissemination
-
Pethe, K.; Alonso, S.; Biet, F.; Delogu, G.; Brennan, M. J.; Locht, C.; Menozzi, F. D. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination Nature 2001, 412, 190-194
-
(2001)
Nature
, vol.412
, pp. 190-194
-
-
Pethe, K.1
Alonso, S.2
Biet, F.3
Delogu, G.4
Brennan, M.J.5
Locht, C.6
Menozzi, F.D.7
-
11
-
-
57049153966
-
Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia
-
Yu, H. H.; Wu, F. L.; Lin, S. E.; Shen, L. J. Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia J. Neurosci. Res. 2008, 86, 2963-2972
-
(2008)
J. Neurosci. Res.
, vol.86
, pp. 2963-2972
-
-
Yu, H.H.1
Wu, F.L.2
Lin, S.E.3
Shen, L.J.4
-
12
-
-
0037179556
-
Recombinant arginine deiminase as a potential anti-angiogenic agent
-
Beloussow, K.; Wang, L.; Wu, J.; Ann, D.; Shen, W. C. Recombinant arginine deiminase as a potential anti-angiogenic agent Cancer Lett. 2002, 183, 155-162
-
(2002)
Cancer Lett.
, vol.183
, pp. 155-162
-
-
Beloussow, K.1
Wang, L.2
Wu, J.3
Ann, D.4
Shen, W.C.5
-
13
-
-
0014802868
-
Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation
-
The, T. H.; Feltkamp, T. E. Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation Immunology 1970, 18, 865-873
-
(1970)
Immunology
, vol.18
, pp. 865-873
-
-
The, T.H.1
Feltkamp, T.E.2
-
14
-
-
33646507726
-
Developing novel hCT derived cell-penetrating peptides with improved metabolic stability
-
Rennert, R.; Wespe, C.; Beck-Sickinger, A. G.; Neundorf, I. Developing novel hCT derived cell-penetrating peptides with improved metabolic stability Biochim. Biophys. Acta 2006, 1758, 347-354
-
(2006)
Biochim. Biophys. Acta
, vol.1758
, pp. 347-354
-
-
Rennert, R.1
Wespe, C.2
Beck-Sickinger, A.G.3
Neundorf, I.4
-
15
-
-
77951903067
-
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
-
Delage, B.; Fennell, D. A.; Nicholson, L.; McNeish, I.; Lemoine, N. R.; Crook, T.; Szlosarek, P. W. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer Int. J. Cancer 2010, 126, 2762-2772
-
(2010)
Int. J. Cancer
, vol.126
, pp. 2762-2772
-
-
Delage, B.1
Fennell, D.A.2
Nicholson, L.3
McNeish, I.4
Lemoine, N.R.5
Crook, T.6
Szlosarek, P.W.7
-
16
-
-
73149106998
-
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4
-
Tsai, W. B.; Aiba, I.; Lee, S. Y.; Feun, L.; Savaraj, N.; Kuo, M. T. Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4 Mol. Cancer Ther. 2009, 8, 3223-3233
-
(2009)
Mol. Cancer Ther.
, vol.8
, pp. 3223-3233
-
-
Tsai, W.B.1
Aiba, I.2
Lee, S.Y.3
Feun, L.4
Savaraj, N.5
Kuo, M.T.6
-
17
-
-
84861154164
-
Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells
-
Tsai, W. B.; Aiba, I.; Long, Y.; Lin, H. K.; Feun, L.; Savaraj, N.; Kuo, M. T. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells Cancer Res. 2012, 72, 2622-2633
-
(2012)
Cancer Res.
, vol.72
, pp. 2622-2633
-
-
Tsai, W.B.1
Aiba, I.2
Long, Y.3
Lin, H.K.4
Feun, L.5
Savaraj, N.6
Kuo, M.T.7
-
18
-
-
9944259578
-
Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway
-
Shen, L. J.; Beloussow, K.; Shen, W. C. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway Biochem. Pharmacol. 2005, 69, 97-104
-
(2005)
Biochem. Pharmacol.
, vol.69
, pp. 97-104
-
-
Shen, L.J.1
Beloussow, K.2
Shen, W.C.3
-
19
-
-
84880515627
-
Polyamines and cancer: Implications for chemotherapy and chemoprevention
-
Nowotarski, S. L.; Woster, P. M.; Casero, R. A., Jr. Polyamines and cancer: implications for chemotherapy and chemoprevention Expert Rev. Mol. Med. 2013, 15, e3
-
(2013)
Expert Rev. Mol. Med.
, vol.15
, pp. 3
-
-
Nowotarski, S.L.1
Woster, P.M.2
Casero, Jr.R.A.3
-
20
-
-
0029966226
-
Whole body nitric oxide synthesis in healthy men determined from [15N]arginine-to-[15N]citrulline labeling
-
Castillo, L.; Beaumier, L.; Ajami, A. M.; Young, V. R. Whole body nitric oxide synthesis in healthy men determined from [15N]arginine-to-[15N]citrulline labeling Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 11460-11465
-
(1996)
Proc. Natl. Acad. Sci. U.S.A.
, vol.93
, pp. 11460-11465
-
-
Castillo, L.1
Beaumier, L.2
Ajami, A.M.3
Young, V.R.4
-
21
-
-
0038743278
-
In vitro uptake and stability study of pVEC and its all-D analog
-
Elmquist, A.; Langel, U. In vitro uptake and stability study of pVEC and its all-D analog Biol. Chem. 2003, 384, 387-393
-
(2003)
Biol. Chem.
, vol.384
, pp. 387-393
-
-
Elmquist, A.1
Langel, U.2
-
22
-
-
0034700141
-
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
-
Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 13003-13008
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 13003-13008
-
-
Wender, P.A.1
Mitchell, D.J.2
Pattabiraman, K.3
Pelkey, E.T.4
Steinman, L.5
Rothbard, J.B.6
-
23
-
-
31344441136
-
Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions
-
Menozzi, F. D.; Reddy, V. M.; Cayet, D.; Raze, D.; Debrie, A. S.; Dehouck, M. P.; Cecchelli, R.; Locht, C. Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions Microbes Infect. 2006, 8, 1-9
-
(2006)
Microbes Infect.
, vol.8
, pp. 1-9
-
-
Menozzi, F.D.1
Reddy, V.M.2
Cayet, D.3
Raze, D.4
Debrie, A.S.5
Dehouck, M.P.6
Cecchelli, R.7
Locht, C.8
-
24
-
-
33748433244
-
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery
-
Mae, M.; Langel, U. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery Curr. Opin. Pharmacol. 2006, 6, 509-514
-
(2006)
Curr. Opin. Pharmacol.
, vol.6
, pp. 509-514
-
-
Mae, M.1
Langel, U.2
-
25
-
-
77958150359
-
Peptide-mediated protein delivery- which pathways are penetrable?
-
Raagel, H.; Saalik, P.; Pooga, M. Peptide-mediated protein delivery- which pathways are penetrable? Biochim. Biophys. Acta 2010, 1798, 2240-2248
-
(2010)
Biochim. Biophys. Acta
, vol.1798
, pp. 2240-2248
-
-
Raagel, H.1
Saalik, P.2
Pooga, M.3
-
26
-
-
2342595835
-
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis
-
Wadia, J. S.; Stan, R. V.; Dowdy, S. F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 2004, 10, 310-315
-
(2004)
Nat. Med.
, vol.10
, pp. 310-315
-
-
Wadia, J.S.1
Stan, R.V.2
Dowdy, S.F.3
-
27
-
-
0036678138
-
Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis
-
Pethe, K.; Bifani, P.; Drobecq, H.; Sergheraert, C.; Debrie, A. S.; Locht, C.; Menozzi, F. D. Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 10759-10764
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 10759-10764
-
-
Pethe, K.1
Bifani, P.2
Drobecq, H.3
Sergheraert, C.4
Debrie, A.S.5
Locht, C.6
Menozzi, F.D.7
-
28
-
-
33646199047
-
Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis
-
Locht, C.; Hougardy, J. M.; Rouanet, C.; Place, S.; Mascart, F. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis Tuberculosis 2006, 86, 303-309
-
(2006)
Tuberculosis
, vol.86
, pp. 303-309
-
-
Locht, C.1
Hougardy, J.M.2
Rouanet, C.3
Place, S.4
Mascart, F.5
-
29
-
-
4644324023
-
Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin
-
Temmerman, S.; Pethe, K.; Parra, M.; Alonso, S.; Rouanet, C.; Pickett, T.; Drowart, A.; Debrie, A. S.; Delogu, G.; Menozzi, F. D.; Sergheraert, C.; Brennan, M. J.; Mascart, F.; Locht, C. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin Nat. Med. 2004, 10, 935-941
-
(2004)
Nat. Med.
, vol.10
, pp. 935-941
-
-
Temmerman, S.1
Pethe, K.2
Parra, M.3
Alonso, S.4
Rouanet, C.5
Pickett, T.6
Drowart, A.7
Debrie, A.S.8
Delogu, G.9
Menozzi, F.D.10
Sergheraert, C.11
Brennan, M.J.12
Mascart, F.13
Locht, C.14
-
30
-
-
0023226153
-
Nutritional requirements of human malignant (leukemic) cell lines: Implications for adjuvant therapy
-
Beebe, D. P.; Faguet, G. B. Nutritional requirements of human malignant (leukemic) cell lines: implications for adjuvant therapy Cancer Res. 1987, 47, 2380-2384
-
(1987)
Cancer Res.
, vol.47
, pp. 2380-2384
-
-
Beebe, D.P.1
Faguet, G.B.2
-
31
-
-
84859268917
-
Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery
-
Zaro, J. L.; Fei, L.; Shen, W. C. Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery J. Controlled Release 2012, 158, 357-361
-
(2012)
J. Controlled Release
, vol.158
, pp. 357-361
-
-
Zaro, J.L.1
Fei, L.2
Shen, W.C.3
-
32
-
-
11144229887
-
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
-
Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17867-17872
-
(2004)
Proc. Natl. Acad. Sci. U.S.A.
, vol.101
, pp. 17867-17872
-
-
Jiang, T.1
Olson, E.S.2
Nguyen, Q.T.3
Roy, M.4
Jennings, P.A.5
Tsien, R.Y.6
|